Dumping Amylin ups stakes for Lilly
Eli Lilly and Co. divorced one diabetes darling in favor of a new flame last week, but no analysts cheered. And a few booed.
Health Care & Life Sciences
Articles
Potential Effient rival shows promise in study
A study showing Johnson & Johnson and Bayer AG’s blood-thinner Xarelto succeeded where rival drugs failed could give the companies entry to a $1 billion-plus market where Eli Lilly already competes.
Terre Haute hospital 6th to back Marian med school
Terre Haute’s Union Hospital is investing $100,000 in Marian University’s new College of Osteopathic Medicine.
WellPoint considers bid for managed care firm
XL Health specializes in chronically ill Medicare members, could help WellPoint profits as baby boomers age.
WellPoint eyes $1.5 billion deal for XLHealth
Offers for XLHealth, a provider of managed care for chronically ill Medicare members, may value the company at $1.5 billion to $2 billion.
Riley promotes chief medical officer to CEO
Dr. Jeff Sperring takes the helm after a leadership void created by the departure of Riley’s CEO and COO in late spring.
Lilly files suit over flea medication sales from Australia
The Indianapolis-based pharmaceutical firm claims an Australian veterinary clinic is infringing on its Comfortis flea medication’s trademark by reselling it to U.S. consumers online.
Cancer-drug firm Endocyte to build commercial team in Indianapolis
Endocyte employs 12 people in Indianapolis and plans to add three or four more commercial executives there over the next year and a half as it anticipates approval of its ovarian cancer medication in Europe.
Study: IU med school, hospitals boost Indiana economy
A new study says biomedical research at the Indiana University School of Medicine and its partner hospitals pumped about $370 million into Indiana's economy in 2009.
New York orders WellPoint to make refunds for overcharges
WellPoint is among 11 insurers ordered to refund money to almost 600,000 New Yorkers who were charged too much for health insurance.
Lilly, Amylin agree to end diabetes partnership
Amylin Pharmaceuticals Inc. and Eli Lilly and Co. have agreed to end a decade-long diabetes partnership to resolve litigation. Amylin will make an upfront payment of $250 million to Lilly and future revenue-sharing payments of $1.2 billion plus interest.
Lilly, Bristol-Myers approved to market wider Erbitux use
Eli Lilly and Co. and Bristol-Myers Squibb Co. won U.S. approval to expand marketing of the cancer drug Erbitux for late-stage head and neck tumors.
Glucose monitor deal helps Roche catch up
Roche Diagnostics will partner with a San Diego firm to incorporate its continuous glucose monitoring sensor with a wireless handheld device Roche is developing to help diabetics test their blood sugar and track their glucose levels throughout the day.
Drug shortages hit Lilly, Endocyte
The nation’s shortage of certain drugs is threatening to affect research trials being conducted by Eli Lilly and Co. and Endocyte Inc.
Carmel free clinic drawing jobless professionals
Trinity Free Clinic in Carmel began in 2000 to serve a growing Hispanic immigrant population. Since the latest recession, so many people—including unemployed professionals—have found their way to the clinic that the portion of white patients has grown from one-third in 2008 to 47 percent last year.
Lilly hid Zyprexa’s diabetes risks, family’s lawyer argues
Eli Lilly and Co. hid the diabetes risks of Zyprexa to protect sales, a lawyer for the family of a 20-year-old patient who died while taking the medicine told a jury in the first case to go to trial over the drug. The attorney asked jurors to award the family $40 million in compensatory damages.
Lilly loses British Supreme Court ruling over gene patent
The British Supreme Court ruled in favor of Human Genome Sciences Inc. in its dispute with Eli Lilly and Co. over the validity of a patent for a gene sequence that could be used to treat people with immune diseases.
Cardinal Fitness closing six area fitness centers
Health-club chain plans to keep six local locations open, but refer members of closed locations to LA Fitness.
IU med school gets $9M for Alzheimer’s center
The grant is the fifth consecutive five-year grant the Alzheimer Disease Center has received from NIH to support research to understand the causes and potential treatments for Alzheimer’s and other forms of dementia.
Indiana officials blast feds for ‘over-regulation’ on reform
Michael Gargano, secretary of the Indiana Family and Social Services Administration, blasted the rules for both “glaring omissions” as well as creating new and unfunded “mandates” not included in the 2010 health reform law